2016 Taubman Prize honorees named
Two clinician-scientists whose groundbreaking work has shown how the human body’s own immune system can fend off cancer will share the 2016 $100,000 Taubman Prize for Excellence in Translational Medical Science, the University of Michigan’s A. Alfred Taubman Medical Research Institute announced.
Suzanne L. Topalian, M.D., professor of surgery and oncology at Johns Hopkins University School of Medicine, and Jedd D. Wolchok, M.D., Ph.D., chief of the immunotherapeutics service at Memorial Sloan Kettering Cancer Center, associate director of the Ludwig Institute, director of the Parker Institute for Cancer Immunotherapy at MSK, and professor of medicine at the Weill Medical College of Cornell University, will receive the honor. Their contributions to immunotherapy are recognized as a new paradigm in the treatment of advanced cancers.
“Harnessing the body’s own defenses to treat and defeat tumors is an important advance in the history of our battle with cancer,” said Eva Feldman, M.D., Ph.D., director of the Taubman Institute, and a professor at the U-M Medical School. “The work of Dr. Topalian and Dr. Wolchok has opened the door to life-saving new options for doctors and their patients, and exemplifies the ethos of the dedicated clinician-scientist. We are honored to recognize their extraordinary contributions.”
Topalian and Wolchok will present keynote talks at the Taubman Institute’s annual symposium on Oct. 21 at the Kahn Auditorium on the U-M medical campus. The symposium is open to the general public.
Read the full media release: http://umhealth.me/1VZmzTQ